Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Modulation of the Dopaminergic System Using Methylphenidate on Memory and Executive Processes in Individuals With 22q11.2 Deletion Syndrome

NCT04647500 is registered in ClinicalTrials.gov with University of Geneva, Switzerland as lead sponsor.

NCT NCT04647500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04647500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Modulation of the Dopaminergic System Using Methylphenidate on Memory and Executive Processes in Individuals With 22q11.2 Deletion Syndrome
Lead sponsor
University of Geneva, Switzerland
Phase
Not applicable
Overall status
Completed
Start date
August 26, 2016
Completion date
September 26, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

22q11.2 deletion syndrome